Abstract
As global ageing deepens and galanthamine is the preferred clinical drug for the treatment of mild to moderate Alzheimer’s disease, it will be valuable to examine the behaviour and mechanism of galanthamine’s thermal decomposition for its quality control, formulation process, evaluation of thermal stability, and expiry date in production. In order to study the pyrolysis of galanthamine hydrobromide with nitrogen as the carrier gas, a thermogravimetric-differential thermogravimetric technique (TG-DTG) was applied at a temperature rise rate of 10 K min−1 and a volume flow rate of 35 mL min−1. The apparent activation energy E a and the prefactor A (E a = 224.45 kJ mol−1 and lnA = 47.40) of the thermal decomposition reaction of galanthamine hydrobromide were calculated according to the multiple heating rate method (Kissinger and Ozawa) and the single heating rate method (Coats-Redfern and Achar), and the most probable mechanism function was derived, and then the storage period was inferred from E a and E. A three-dimensional diffusion mechanism was suggested to control the thermal decomposition of galanthamine hydrobromide in accordance with the Jander equation, random nucleation and subsequent growth control, corresponding to the Mample one-way rule and the Avrami-Erofeev equation. As a result, the thermal decomposition temperature of galanthamine hydrobromide gradually increased with the rate of temperature rise. From Gaussian simulations and thermogravimetric data, galanthamine hydrobromide decomposed at the first stage (518.25–560.75 K) to release H2O, at the second stage (563.25–650.75 K) to generate CO, CO2, NH3 and other gases, and finally at the third stage (653.25–843.25 K) to release CO2. After 843.25 K, the residual molecular skeleton is cleaved to release CO2 and H2O. According to the E a and A presenting in the first stage of thermal decomposition, it is assumed that the storage life of galanthamine hydrobromide at room temperature 298.15 K is 4–5 years.
Keywords: galanthamine hydrobromide, TG-DTG, thermal decomposition kinetics, gaussian simulation, shelflife
1 Introduction
Alzheimer’s disease (AD) currently is the fourth most common disease causing death in the world, following heart disease, cancer and stroke (Tariot et al., 2012), and attracting the attention of researchers worldwide. The number of people affected by AD is expected to exceed 114 million by 2050 (Liu et al., 2018). And among the 10 diseases that cause the most deaths worldwide each year, AD is the only disease that cannot be effectively cured or controlled (Li et al., 2016). Considering the medical and economic burden of treating AD (Zhang et al., 2022), the development of highly effective and less toxic drugs for AD has become a critical issue to be addressed. At present, there is no specific treatment for AD, and clinical treatment with acetylcholinesterase inhibitor (AChEI) drugs is commonly used (Pereira et al., 2022). The natural products are an important source of AChEI, and the identification of AChEI from plants with high selectivity and low toxic side effects has been the top research area in the pharmaceutical field (Chen et al., 2016), as well as being the most inspiring topic for investigating and developing drug treatment of AD.
Natural products with their novel structures, multiple targets and diverse activities are an attractive source of lead compounds for the treatment of AD (Zhang et al., 2022). In recent years, alkaloids, terpenoids, flavonoids and other monomeric components suitable for long-term administration, with low toxic side effects and AChE inhibitory activity have been identified, of which alkaloids account for a large proportion (Zhang and Zou, 2020). A representative natural product for the treatment of AD is the isoquinoline alkaloid galanthamine, which is the best option available (Li et al., 2019) to treat mild or severe AD patients through directly improving their cognitive function (Burns et al., 2009; Huang et al., 2020). Galanthamine is also indicated for the treatment of post-polio, myasthenia gravis, closed-angle glaucoma, peritonitis and post-operative intestinal muscle paralysis, and inhibits the release of tumour necrosis factor (Zhou and Su, 2008; Liu et al., 2010; Akram et al., 2020). Galanthamine is present in very low levels in Lycoris Herb. But Lycoris Herb is the main source plant for the extraction of galanthamine (Moraes-Cerdeira et al., 1997), with levels varying depending on the species and organ of lithops (Tian et al., 2018). Previous studies have been intended to attempt the chemical synthesis of galanthamine, but industrial-scale production has not been achieved due to the complicated synthesis steps, harsh conditions, high costs, low yields and serious environmental pollution (Zhang et al., 2019). A green and high yield extraction process for galanthamine is a hot research topic (Tian et al., 2016; Akram et al., 2020; Lekhak et al., 2021). Galanthamine is unstable in air, and salt modification is generally adopted to improve its stability (Liu, 2006), but studies on thermal stability and decomposition mechanism have not been reported. Therefore, it is an important practical guidance to carry out the evaluation of the stability and storage period of galanthamine for its effective application.
Thermal analysis technique allows the study of physical changes (such as crystalline transformation, phase change and adsorption) and chemical changes (such as dehydration, chemistry and decomposition) of compounds during the process of programmed temperature control (Liu et al., 2019), and is an important method to examine the thermal stability of drugs (He et al., 2018; Simon et al., 2021; Wang et al., 2022). Understanding the mechanisms of thermal decomposition of drugs and their corresponding intermediates is essential to provide a systematically predictive approach to unknown toxic products, to infer the feasibility of the large-scale synthesis, to predict whether long-term stable storage is possible and to anticipate the sensitivity of product to various external stimuli, for example, as thermal and mechanical effects (Justino et al., 2022). For example, the mechanism of thermal decomposition of gemcitabine (GTB), a nucleoside analog for chemotherapy of multiple cancers, was determined and characterized as a gaseous product and a residue of thermal decomposition through various thermal analysis techniques. The results suggested a strong charge transfer (CT) structure formed by the two strongly electronegative fluorine atoms on the furan ring. Such a strong CT structure significantly reinforces the strength of the N-glycosidic and weakest bonds, resulting in more thermal stability and a unique thermal decomposition mechanism (Wu et al., 2018).
TGA is widely applied as an effective pyrolyzer to study the kinetics of pyrolysis reactions of substances. The two most commonly used and important models are the isothermal and non-isothermal models. Non-isothermal techniques offer a smaller range of error than isothermal models, which require constant temperature times and rates in the process, and therefore non-isothermal models are less time-consuming to study or experiment with and yield more accurate data. In addition, kinetic analyzes can be performed in an uninterrupted method over a wide range of temperatures, thus reducing the potential for errors in thermochemical induction methods (Mishra and Mohanty, 2018). For example, in a study of the kinetic properties and pyrolytic behaviour of Azadirachta indica (NM) and Phyllanthus emblica kernel (AM) using TGA, the authors employed six model-free techniques, Kissinger-Akahira-Sunose, distributed activation energy model, Friedman, Coats-Redfern, Ozawa-FlynnWall, Vyazovkin and Criado, to evaluate kinetic parameters at five different heating rates (10°C–50°C min−1) and thus demonstrate that AM and NM undergo various reaction mechanisms during pyrolysis (Mishra and Mohanty, 2020).
In this work, the thermogravimetric dynamic analysis (TG-DTG) curves and Fourier transform infrared spectroscopy (FTIR) spectra of galanthamine were plotted at different rates of temperature rise, based on the previous studies on the thermal stability of lithophan and ricoramine (Tian and Xiao, 2012; Ling et al., 2022). The kinetic parameters of galanthamine pyrolysis and the volatile product characteristics at different stages were calculated using the Kissinger, Ozawa, Achar and Coats-Redfern methods in collaboration. It provides an effective scientific proof for improving extraction and synthesis processes, formulation quality, and rational drug use by determining the storage life of galanthamine and analyzing its decomposition process.
2 Experimental
2.1 Sample
Galanthamine hydrobromide (98%) was purchased from Shanghai haring biotechnology co., LTD batch number: HL0926AS, molecular mass: 368.27.
2.2 Thermal analysis
The data of thermal decomposition kinetics of galanthamine hydrobromide was acquired from the test examined by thermogravimetric analyzer (NETZSCH TG 449C, Berlin, Germany), and the adjustment of functional groups among the thermal decomposition was investigated by FTIR spectrophotometer (Bruker Tensor 27 FTIR, Berlin, Germany). Additionally, an FTIR test was performed using a DTGS detector, while N2 flow was measured using a mass flow controller. A TG-DTG study of galanthamine hydrobromide (10 mg) was performed under a nitrogen flow (35 mL min−1) from 313.15 to 1,173.15 K at different heating rates (5, 10, 20 K min−1) (Zhang et al., 2016), which the data was analyzed for the kinetic studies of galanthamine hydrobromide. Plus, in order to prevent condensation of the evolved gases, a pipe and a flow cell (preheated to 453.15 K) were used to connect the FTIR instrument to the TG analyzer. With a scanning range of 4,000 cm−1 to 600 cm−1, FTIR real-time tracking mode could be used to measure the spectra of decomposed compounds during galanthamine hydrobromide pyrolysis. (Lopes et al., 2018).
2.3 Methodology and kinetics analysis
According to the references (Vyazovkin et al., 2011; Lopes et al., 2018), the TG-DTG data at 5, 10, and 20 K min−1 were evaluated by the multiple warming rate method (Kissinger, Flynn-Wall-Ozawa method) and the single warming rate method (Coats-Redfern and Achar method), and the four methods were mutually validated to infer the shelf life of galanthamine hydrobromide based on the values of the activation energy of pyrolysis (E a ) and the pre-finger factor (A) (Xiao et al., 2013).
2.3.1 Multiple temperature rise rate analysis (Kissinger)
Based on the maximum thermal weight loss rate temperature (Tp) of galanthamine hydrobromide at different heating rates (β), the linear relationship between the two was obtained by ln (β/Tp 2 ) plotted against 1/Tp and linearly fitted using least squares, and the kinetic parameters E a , A and the correlation coefficient (r) were obtained from the slope and intercept of the straight line. The equation is given in (1).
| (1) |
Herein, β means the heating rate, K min−1; Tp corresponds to the absolute temperature at which the mass loss rate achieves its maximum, K; E a represents activation energy, kJ mol−1; R is the gas constant 8.314 J (mol K)−1, and A indicates the pre-exponential factor, min−1.
2.3.2 Multiple temperature rise rate analysis (Ozawa)
Calculations of the kinetic parameters E a and A were then obtained through selecting T corresponding to the same conversion rate at different rates of warming, plotting 1/T by lgβ and performing a self-programmed linear regression of the basic data according to the least squares method. The equation is given in (2).
| (2) |
Both g(α) and T denote the most likely integral form of the mechanism function and the thermodynamic temperature, respectively. Additionally, all other symbols are identical in meaning as described above (section 2.3.1).
2.3.3 Single temperature rise rate analysis (Coats-Redfern)
After plotting ln[g(α)/T] versus 1/T for different T corresponding to different conversion rates at the same rate of warming, a straight line was obtained. Linear regression was performed using ordinary least squares, in which E a and A were subsequently calculable from the intercept ln (AR/βE a ) and the slope E a /R. The equation is displayed as (3).
| (3) |
Where α means conversion rate (%), and all the other symbols in the equation share the same meaning as above.
2.3.4 Achar method
| (4) |
Again, f(α) is the function of the differential form mechanism. 1/T is graphed by ln(dα/dt)/f(α) and the data are fitted using the ordinary least squares. E a and A are computed separately from the linear intercept lnA and the slope (-Ea/RT).
2.4 Molecular bond level simulation
The preliminary structures of the reactant molecules were acquired by ChemBioDraw in ChemBio Office 2014 software as well as structure optimisation in ChemBio3D. Next, the optimised structures and molecular bond orders were computed by Gaussian09 at the B3LYP/6-31+G(d,p) level using Density Functional Theory (Rani et al., 2020). In addition, default sets the calculation accuracy and convergence in the procedure.
3 Results and discussion
3.1 Pyrolysis mechanism deduction of galanthamine hydrobromide
Since each molecule of galanthamine hydrobromide consists of galanthamine, HBr, in this research, the size of the organic covalent bonds between atoms in the galanthamine molecule was simulated by molecular simulation techniques. The main bond levels of the galanthamine molecule are shown in Figure 1.
FIGURE 1.

Molecular bond orders of galanthamine.
The TG-DTG curve of galanthamine hydrobromide (5,10, 20 K min−1) are indicated in Figure 2, which showed that galanthamine hydrobromide remained stable with a smooth curve until 518.25 K, after which thermal decomposition started at 518.25 K. A lower heating rate results in a higher residual molecular mass and a lower maximum degradation rate. Only one mass loss step was observed from the TG curve after 518.25 K, which was caused by the inclusion of three consecutive weight loss processes identified in the DTG curve. From the three processes of thermal decomposition of galanthamine hydrobromide in Table 1, at a heating rate of 10 K min−1, between 518.25 and 560.75 K in the first stage, the molecular mass loss is 9.07% was inferred that there occurred the breakage of the C5-C15, O16-C13 and O15-C10 bonds in the molecule of galanthamine. If the molecule loses two O atoms, the theoretical mass loss rate is 8.64%, comparing the actual mass loss of 9.07%, which is generally compatible. During the second stage, the molecular mass loss from 563.25 to 650.75 K achieves 47.41%. According to the DTG curve of the decomposition rate by heating at 10 k/min, it was surmised from the bond strength and mass loss rate of galanthamine that hydrobromic acid decomposed from the molecule at this stage and the chemical breakage of C9-C10, C9-C11, N18-C17 and N18-C20 connected to form small molecules of escaped gas and the molecule lost 6 C, 1 N, 9 H and 1 Br. The theoretical mass loss of 47.27% is consistent with the actual mass loss. The third stage of decomposition occurs from 653.25 to 843.25 K, with a molecular mass loss of 18.57%. The breakage of the C6-O7 and C4-C9 bonds in the galanthamine molecule is estimated from the bond strength, leading to a molecular loss of 4 C, 1 O and 8 H. Loss of theoretical mass is 19.45%, which corresponds to the practical loss of mass. After 843.25 K, there was no significant step decrease in the TG curve for this process and the DTG curve remained level. It is assumed that the process is dominated by the slow mass loss resulted by the intensive cracking and carbonisation of the residual skeletal toluene, releasing some gases such as CO2 and H2O. The decomposition scheme is illustrated in Figure 3.
FIGURE 2.

Galanthamine hydrobromide TG-DTG curves under different heating rates (1–5 K min−1, 2–10 K min−1, 3–20 K min−1).
TABLE 1.
Characteristic parameters in the every-stage thermal decomposition of galanthamine hydrobromide (β = 10 K min−1).
| First stage | The second stage | The third stage | |
|---|---|---|---|
| Temperature interval (K) | 518.25–560.75 | 563.25–650.75 | 653.25–843.25 |
| Time interval (min) | 20.2–24.4 | 24.40–33.5 | 33.5–52.97 |
| Step of mass loss (%) | 99.53–90.46 | 90.46–43.05 | 43.05–24.48 |
| Mass loss (%) | 9.06818 | 47.41 | 18.57 |
FIGURE 3.
Thermal decomposition scheme of galanthamine hydrobromide.
3.2 Cracked situation of chemical bond
Three-dimensional infrared spectra (3D, FTIR) of the temperature dependence of the escaping gas during the thermal decomposition of galanthamine hydrobromide at 10 K min−1 are shown in Figure 4. As illustrated in Figure 4, the variation of the intensity of the spectral lines in the direction of time is comparable to the results of the TG. Nevertheless, since the time delay between TG and FTIR, the temperatures of the spectral intensity peaks were dictated by TG, so that information on absorbance levels for different wave numbers and different times are available from the FTIR spectra (Liu et al., 2015). The progression of the thermal decomposition of galanthamine is illustrated in Figure 5. Firstly, between 518.15 and 560.75 K (20–24.4 min), a stretching vibration peak of the O-H (3,870.45 cm−1) functional group was detected, supporting the previously inferred breakage of the three chemical bonds C5-C15, O16-C13 and O15-C10 in the decomposition molecule of galanthamine hydrobromide in the first step to produce H2O. The second step occurred from 563.25 to 650.75 K (24.4–33.5 min), and in addition to the above-mentioned vibrations of functional groups and their further enhancement, CO2 (2,337.04 cm−1, 620.28 cm−1), C-H (2,936–3,022 cm−1, 1,035.11 cm−1), N-H (3,627 cm−1) and C-O-C (1,056 cm−1) in stretching and bending vibrations, indicating successive fracture and cleavage with N18-C19, C5-O15-C10, resulting in the creation of CO, CO2 NH3, alcohols, ethers, etc. In the third step, stretching and bending vibrations of simple groups such as CO2 (2,305–2,362 cm−1, 667 cm−1) were detected at temperatures of 653.25–843.25 K (33–53 min), corroborating the successive breakage of atoms in the branched chains connected to N18 in this step to produce CO2, etc.
FIGURE 4.

3D IR spectrum of galanthamine hydrobromide with rate of 10 K min−1.
FIGURE 5.

IR spectrum of galanthamine hydrobromide.
3.3 Thermal decomposition kinetics
3.3.1 Thermal decomposition kinetics
As molecular decomposition happened during the second mass loss, a kinetic analysis was performed for the second mass loss step. Multiple temperature rise rate analysis: The kinetic parameters were derived by the multiple heating rate method and the thermal decomposition of galanthamine hydrobromide with varying heating rates (5, 10, and 20 K min−1) in TG-DTG were analysed by the multiple Kissinger and Ozawa methods (Figure 2). The relevant details in the TG-DTG curves are shown in Table 2. Based on the results in Table 2, both of the multi-stage methods used for the theoretical analysis in this study can be undertaken simultaneously, and in turn the kinetic parameters are derived from the equations, as shown in Table 3. In fact, the difference between the activation energy calculations of the Kissinger and Ozawa methods is minimal, both indicating that the activation energy first rises and then drops during the second thermal decomposition step.
TABLE 2.
Data from the TG-DTG curve for the two-step thermal decomposition of galanthamine hydrobromide.
| Heating rate β (K min−1) | Temperature for max pyrolysis speed at different heating rates Tp (K) | ||
|---|---|---|---|
| First stage | The second stage | The third stage | |
| 5 | 535.25 | 593.55 | 674.05 |
| 10 | 538.25 | 611.45 | 683.55 |
| 20 | 547.75 | 625.95 | 697.95 |
TABLE 3.
Kinetic parameters obtained by Kissinger method and Ozawa method.
| Method | First stage | The second stage | The third stage | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ea (kJ mol−1) | lnA | R 2 | Ea (kJ mol−1) | lnA | R 2 | Ea (kJ mol−1) | lnA | R 2 | |
| Kissinger | 190.81 | 35.08 | 0.9994 | 133.02 | 18.49 | 1 | 215.96 | 30.34 | 0.9855 |
| Ozawa | 184.51 | — | 0.9997 | 125.16 | — | 0.9943 | 213.56 | — | 0.9883 |
3.3.2 Extrapolation of function of the pyrolysis Mechanism
The kinetics of the TG-DTG curves under 10 K min−1 were processed based on the data in Table 4 with the generic Achar method and the Coats-Redfern method. The differential and integral methods can be worked out simultaneously and corroborate each other. After substituting the values of T, α and dα/dt in Table 4 into the 40 commonly available mechanism functions (Hu and Shi, 2001; Ren et al., 2007), the corresponding f(α) and g(α) values were calculated and then the Coats-Redfern equation and the differential method Achar equation were solved from the f(α) and g(α) values. A linear fit by least squares gives the values of E a , lnA and r 2 and the corresponding data are collected in Table 5. Upon fitting to an excellent linear correlation (close to 1) and where the values of E a and lnA as computed via either method above are closest, which corresponds to the numbering mechanism function that is most compatible with the reaction, there is no doubt that the appropriate E a and A are the activation energy and pre-exponential factor of the reaction, respectively.
TABLE 4.
Masslessness data by Achar and Coats-Redfern methods (β = 10 K min−1).
| First stage | The second stage | The third stage | ||||||
|---|---|---|---|---|---|---|---|---|
| Temperature (K) | Percent conversion (%) | Conversion rate (%/min) | Temperature (K) | Percent conversion (%) | Conversion rate (%/min) | Temperature (K) | Percent conversion (%) | Conversion rate (%/min) |
| 538.25 | 0.1036 | 0.3289 | 595.75 | 0.2391 | 0.1505 | 725.75 | 0.6626 | 0.0665 |
| 540.75 | 0.2061 | 0.5299 | 598.25 | 0.2805 | 0.1694 | 733.25 | 0.7104 | 0.0603 |
| 543.25 | 0.3835 | 0.6732 | 600.75 | 0.3264 | 0.1855 | 738.25 | 0.7401 | 0.0567 |
| 545.75 | 0.5802 | 0.6564 | 603.25 | 0.3754 | 0.1986 | 740.75 | 0.7540 | 0.0549 |
| 548.25 | 0.7142 | 0.5394 | 605.75 | 0.4276 | 0.2093 | 748.25 | 0.7935 | 0.0491 |
| 550.75 | 0.8039 | 0.3783 | 608.25 | 0.4822 | 0.2169 | 753.25 | 0.8173 | 0.0460 |
| 610.75 | 0.5384 | 0.2203 | 758.25 | 0.8398 | 0.0430 | |||
| 618.25 | 0.7031 | 0.2053 | 768.25 | 0.8798 | 0.0356 | |||
| 628.25 | 0.8756 | 0.1233 | ||||||
TABLE 5.
Lineary dependent kinetic parameters by Achar and Coats-Redfern methods (β = 10 K min−1).
| Stage | No | Coats-Redfern method | Achar method | ||||
|---|---|---|---|---|---|---|---|
| lnA | Ea (kJ mol–1) | r 2 | lnA | Ea (kJ mol–1) | r 2 | ||
| Frist stage | 5 | 44.36 | 236.46 | 0.9529 | 62.752 | 286.4 | 0.9935 |
| 36 | 60.74 | 301.84 | 0.971 | 142.94 | 643.27 | 0.9911 | |
| 37 | 150.3 | 707.85 | 0.9906 | 107.52 | 487.82 | 0.9733 | |
| 41 | 130.88 | 612.73 | 0.9718 | 212.91 | 954.36 | 0.9976 | |
| Second stage | 9 | 79.1 | 118.02 | 0.9991 | 80.633 | 420.3 | 0.9987 |
| 16 | 25.5 | 169.28 | 0.991 | 25.007 | 131.54 | 0.9658 | |
| 17 | 44.58 | 801.64 | 0.9914 | 43.002 | 221.32 | 0.9786 | |
| 18 | 228.95 | 348.83 | 0.9916 | 60.81 | 872.34 | 0.9831 | |
| 19 | 96.72 | 528.37 | 0.9918 | 96.256 | 490.63 | 0.9868 | |
| 20 | 125.15 | 707.92 | 0.9919 | 131.58 | 175.12 | 0.9884 | |
| Third stage | 9 | 18.92 | 166 | 0.9999 | 26.492 | 175.12 | 0.9982 |
| 17 | 7.37 | 89.2 | 0.9994 | 12.282 | 81.3 | 0.9982 | |
| 18 | 13.76 | 125.47 | 0.9994 | 18.624 | 117.56 | 0.9994 | |
| 19 | 26.33 | 197.98 | 0.9995 | 31.139 | 190.08 | 0.9999 | |
| 20 | 38.75 | 270.5 | 0.9995 | 43.537 | 262.6 | 1.0000 | |
| 35 | 18.36 | 18.29 | 0.9977 | 71.116 | 402.3 | 0.9928 | |
| 37 | 52.88 | 302.37 | 0.9945 | 45.763 | 237.53 | 0.9994 | |
Extrapolation of kinetic parameters: The results in Table 5 show that No.5 is the mechanism function of mass loss for the first step; The second step showed a superior linear correlation (r close to 1), resulting in a mechanism function of No. 16; similarly, the third step had a superior linear correlation (r close to 1) and an incentive function of No. 19. The E a and lnA obtained for the two conditions above are the most similar, and the E a and lnA derived from the Achar and Coats-Redfern equations do not differ much from those calculated by the Ozawa and Kissinger methods. The first thermal decomposition step is a three-dimensional diffusion control mechanism corresponding to the Jander equation, with reaction level n = 1/2, differential mechanism function f(α) = 6(1-α) 2/3 [1-(1-α) 1/3 ] 1/2 and integral mechanism function g(α) = [1-(1-α) 1/3 ] 1/2 . The second thermal decomposition step is a stochastic nucleation and subsequent growth control mechanism satisfying the Mample Single row rule, S-shaped α-t curve, number of reaction levels n = 1, differential mechanism function f(α) = 1-α and g(α) = −ln(1-α). The third thermal decomposition step is a random nucleation and subsequent growth control mechanism that conforms to the Avrami-Eroeev equation with reaction level n = 3 and differential mechanism functions f(α) = 1/3(1-α)[-ln(1-α)] −2 and g(α) = [-ln(1-α)] 3 .
3.3.3 Extrapolation of kinetic parameters
A summary of the two sets of values from Tables 3, 5, which were computed from the multiple heating rate and single heating rate methods, is summarised in Table 6, and the kinetic parameters were identified from Table 6. E a and lnA in the first step were indicated to be 224.45 kJ mol−1 and 47.4, respectively. As in step 2, E a = 139.75 kJ mol−1 and lnA = 23.00. In the meantime, among the third step, E a = 204.40 kJ mol−1 and lnA = 29.27. Although the mass loss of galanthamine hydrobromide underwent only a single phase, an inconsistent mechanism of the three phases was suggested with the DTG peak showing micropeaks. The discrepancy between the projected functional mechanism model and the kinetic parameters also supports this inference.
TABLE 6.
Thermal decomposition kinetic parameters.
| Method | First stage | The second stage | The third stage | ||||||
|---|---|---|---|---|---|---|---|---|---|
| lnA | Ea (kJ mol−1) | r 2 | lnA | Ea (kJ mol−1) | r 2 | lnA | Ea (kJ mol−1) | r 2 | |
| Achar | 62.75 | 286.00 | 0.9935 | 25.007 | 131.54 | 0.9658 | 31.14 | 190.08 | 0.9999 |
| Coats-Redfern | 44.36 | 236.46 | 0.9529 | 25.50 | 169.28 | 0.9910 | 26.33 | 197.98 | 0.9995 |
| Ozawa | — | 184.51 | 0.9997 | — | 125.16 | 0.9943 | — | 213.56 | 0.9883 |
| Kissinger | 35.08 | 190.81 | 0.9994 | 18.49 | 133.02 | 1.0000 | 30.34 | 215.96 | 0.9855 |
| Average | 47.40 | 224.45 | — | 23.00 | 139.75 | — | 29.27 | 204.40 | — |
3.4 Evaluation of the storage period
In general the storage period of galanthamine hydrobromide is inferred from the apparent activation energy (E a = 224.45 kJ mol−1) and the pre-exponential factor (lnA = 47.4) obtained in the second pyrolysis stage. Then, at a given reaction temperature T C , the reaction rate constant, k = 1.8339E-19, was calculated according to the equation k = Ae -E a /RT c , after which the negative logarithm (pk) of the decomposition reaction rate constant (k) was further determined. At storage temperature of 298.15 K, the pk value of the drug correlates with the storage period of the drug product. That is, a storage expiry date of 1.5–2 a within the range of pk < 7.5, while a storage expiry date of 3 a within the range of 7.5 < pk < 11, and a storage period of 4–5 a for approximately pk > 10.5. In this study, the negative logarithm pk of the rate constant for the catalytic degradation of galanthamine hydrobromide was calculated at room temperature of 298.15 K and was 18.74, which lies in the range of pk > 10.5, inferring a storage life of 4–5 a for galanthamine hydrobromide.
4 Conclusion
The thermogravimetric-differential thermogravimetric (TG-DTG) analysis technique was adopted to analyse the pyrolysis of galanthamine hydrobromide at different temperature rise rates. The results indicated that the thermal weight loss of galanthamine hydrobromide was classified into three stages (10 K min−1): The first stage was 503.25 K–560.75 K with a weight loss rate of 9.0659%; the second stage was 563.25 K–650.75 K with a weight loss rate of 47.41%; and the third stage was 653.25 K–843.25 K with a weight loss rate of 18.17%. The first step of the thermal decomposition mechanism function of galanthamine hydrobromide was determined to be a three-dimensional diffusion-controlled mechanism, by the simultaneous solution of four methods, including single and multiple ramp rates, satisfying the Jander equation with a reaction level n = 1/2, a differential mechanism function f(α) = 6(1-α) 2/3 [1-(1-α) 1/3 ] 1/2 and a complete mechanism function g(α) = [1-(1-α) 1/3 ] 1/2 . Calculations gave E a = 224.45 kJ mol−1 and lnA = 47.40. As deduced from the Arrhenius formula, E a and InA, the storage period of galanthamine hydrobromide is 4–5 years if stored at room temperature (298.15 K) under nitrogen atmosphere. In this study, we found that galanthamine was stably bound to hydrobromic acid and was difficult to decompose, indicating that galanthamine hydrobromide is thermally stable. The results may provide a basis for quality control and evaluation of galanthamine containing drugs.
Funding Statement
This work was funded by the National Natural Science Foundation of China (32160388).
Data availability statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
Author contributions
CT conceived the research ideas and directed the overall project. CQ and CT designed and performed the experiments. CQ and WL made collected and analyzed the TG data. CQ and CT co-wrote the paper. All authors discussed the results and commented on the different versions of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- Akram M. N., Verpoorte R., Pomahacova B. (2020). Methods for the analysis of galanthamine and its extraction from laboratory to industrial scale. S. Afri. J. Bot. 136, 51–64. 10.1016/j.sajb.2020.08.004 [DOI] [Google Scholar]
- Burns A., Bernabei R., Bullock R., Jentoft A. J. C., Frölich L., Hock C., et al. (2009). Safety and efficacy of galantamine (reminyl) in severe Alzheimer's disease (the SERAD study): A randomised, placebo-controlled, double-blind trial. Lancet. Neurol. 8 (1), 39–47. 10.1016/s1474-4422(08)70261-8 [DOI] [PubMed] [Google Scholar]
- Chen H. W., He X. H., Yuan R., Wei B. J., Chen Z., Dong J. X., et al. (2016). Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo . Fitoterapia 110, 142–149. 10.1016/j.fitote.2016.03.011 [DOI] [PubMed] [Google Scholar]
- He M. J., Lv C. Z., Wang B., Meng X. L., Zhang S. S. (2018). Preliminary investigation on processing mechanism of kansui radix by liquorice based on thermal analysis technology. Chin. J. Chin. Mat. Med. 43 (21), 4255–4263. 10.19540/j.cnki.cjcmm.2018.0112 [DOI] [PubMed] [Google Scholar]
- Hu R. Z., Shi Q. Z. (2001). Thermal analysis kinetics. Beijing, China: Science Press, 127–131. [Google Scholar]
- Huang L. J., Zhao C. Y., Feng X. H., Lan J. Q., Tang J. S., Wang Q. L., et al. (2020). Exploration of nonclinical pharmacodynamics evaluation system of Alzheimer’s disease. Acta Pharm. Sin. 55 (5), 789–805. 10.16438/j.0513-4870.2019-0899 [DOI] [Google Scholar]
- Justino A., Carvalho A. C. S., de Vasconcelos L. G., Gai B. M., Stein A. L., Siqueira A. B. (2022). Tryptophan methyl ester: A proposal of the thermal decomposition mechanism. J. Therm. Analysis Calorim. 147 (14), 7741–7748. 10.1007/s10973-021-11089-3 [DOI] [Google Scholar]
- Lekhak M. M., Patel S. B., Otari S. S., Lekhak U. M., Ghane S. G. (2021). Bioactive potential and RP-HPLC detection of phenolics and alkaloids (lycorine and galanthamine) from ultrasonic-assisted extracts of Crinum roots. S. Afr. J. Bot. 149, 923–936. 10.1016/j.sajb.2021.07.024 [DOI] [Google Scholar]
- Li D. D., Zhang Y. H., Zhang W., Zhao P. (2019). Metaanalysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of alzheimer’s disease. Front. Neurosci. 13, 472. 10.3389/fnins.2019.00472 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Y., Feng Z. M., Li N., Pang L. X. (2016). Drug treatment for senile dementia. Occup. Health 32 (1), 131–134. 10.13329/j.cnki.zyyjk.2016.0089 [DOI] [Google Scholar]
- Ling W. H., Qin C., Tian C. L., Feng M., Wang C. C. (2022). Thermogravimetric infrared analysis for the pyrolysis mechanism and shelf life of lycoramine hydrobromide. Int. J. Chem. Kinet. 54 (3), 133–141. 10.1002/kin.21547 [DOI] [Google Scholar]
- Liu D., Gao J. H., Wang H., Wu C. L., Lei N. (2019). Application of thermal analysis technology in pharmaceutical analys. Anal. Instrum. 2, 8–13. 10.3969/j.issn.1001-232x.2019.02.002 [DOI] [Google Scholar]
- Liu T. (2006). Study on the synthesis process of galantamine. Hangzhou, China: Zhejiang University. [Google Scholar]
- Liu X. L., Cao P., Yang J. Z., Zhao D. Z.(2018). Linearized and kernelized sparse multitask learning for predicting cognitive outcomes in Alzheimer’s disease. Comput. Mathem. Methods. Med. 2018, 1–13. 10.1155/2018/7429782 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Y., Li Z. F., Wang J. S., Zhu P., Zhao J. C., Zhang C. J., et al. (2015). Thermal degradation and pyrolysis behavior of aluminum alginate investigated by TG-FTIR-MS and Py-GC-MS. Polym. Degrad. Stab. 118, 59–68. 10.1016/j.polymdegradstab.2015.04.010 [DOI] [Google Scholar]
- Liu Z. H., Ma Y. F., Wu J. S., Gan J. X., Xu S. W., Jiang G. Y. (2010). Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis. Chin. Med. J. 123 (13), 1727–1730. 10.3760/cma.j.issn.0366-6999.2010.13.021 [DOI] [PubMed] [Google Scholar]
- Lopes F. C. R., Pereira J. C., Tannous K. (2018). Thermal decomposition kinetics of guarana seed residue through thermogravimetric analysis under inert and oxidizing atmospheres. Bioresour. Technol. 270, 294–302. 10.1016/j.biortech.2018.09.021 [DOI] [PubMed] [Google Scholar]
- Mishra R. K., Mohanty K. (2020). Kinetic analysis and pyrolysis behaviour of waste biomass towards its bioenergy potential. Bioresour. Technol. 311, 123480. 10.1016/j.biortech.2020.123480 [DOI] [PubMed] [Google Scholar]
- Mishra R. K., Mohanty K. (2018). Pyrolysis kinetics and thermal behavior of waste sawdust biomass using thermogravimetric analysis. Bioresour. Technol. 251, 63–74. 10.1016/j.biortech.2017.12.029 [DOI] [PubMed] [Google Scholar]
- Moraes-Cerdeira R. M., Burandtjr C. L., Bastos J. K., Nanayakkara N. P. D., Mikell J., Thurn J., et al. (1997). Evaluation of four Narcissus cultivars aspotential sources for galanthamine production. Planta Medica 63 (5), 472–474. 10.1055/s-2006-957740 [DOI] [PubMed] [Google Scholar]
- Pereira G. R. C., Gonçalves L. M., Abrahim-Vieira B. A., Mesquita J. F. D. (2022). In silico analyses of acetylcholinesterase (AChE) and its genetic variants in interaction with the anti‐Alzheimer drug Rivastigmine. J. Cell. Biochem. 123, 1259–1277. 10.1002/jcb.30277 [DOI] [PubMed] [Google Scholar]
- Rani T. D., Rajkumar M., Vinitha G., Mobika J., Chandramohan A. (2020). Synthesis, structural, thermal, mechanical, laser damage threshold and DFT investigations on bis (2-methylimidazolium-4-aminobenzoate) single crystal. J. Mol. Struct. 1200, 127045. 10.1016/j.molstruc.2019.127045 [DOI] [Google Scholar]
- Ren N., Zhang J. J., Zhang C. Y., Su S. L., Zhang H. Y., Tian L. (2007). Thermal decomposition kinetics of Sn (III) complex with o-nitrobenzoate and 1,10- phenanthroline. Chin. J. Inorg. Chem. 23, 1078–1084. [Google Scholar]
- Simon Á., Smarandache A., Tozar T., Andrei I. R., Stoicu A., van Loon J. J. W. A., et al. (2021). Photoactive chlorpromazine and promazine drugs exposed to hypergravity conditions after interaction with UV laser radiation. Acta Astron 189, 260–268. 10.1016/j.actaastro.2021.08.038 [DOI] [Google Scholar]
- Tariot P., Salloway S., Yardley J., Mackell J., Moline M. (2012). Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease. BMC Res. Notes. 5 (1), 283. 10.1186/1756-0500-5-283 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tian C. L., Qin C., Wang P. (2018). Ultrasonic-enzymatic synergistic extraction and content comparison of Lycoris alkaloids. J. Chin. Med. Mat. 41 (9), 2167–2170. 10.13863/j.issn1001-4454.2018.09.033 [DOI] [Google Scholar]
- Tian C. L., Wang P., Qin J. X., Liu X. P., Song K., Xiao Z. B. (2016). Enzyme-assisted extraction and enrichment of galanthamine from Lycoris aurea . Chin. Herb. Med. 8 (2), 182–188. 10.1016/S1674-6384(16)60028-X [DOI] [Google Scholar]
- Tian C. L., Xiao Z. B. (2012). Thermal decomposition mechanism and kinetics of lycorine hydrochloride. Chem. Ind. For. Prod. 32 (5), 77–82. [Google Scholar]
- Vyazovkin S., Burnham A. K., Criado J. M., Pérez-Maqueda L. A., Popescu C., Sbirrazzuoli N. (2011). ICTAC Kinetics Committee recommendations for performing kinetic computations on thermal analysis data.Thermochim. Acta. 520 (1-2), 1–19. 10.1016/j.tca.2011.03.034 [DOI] [Google Scholar]
- Wang L., Yuan P. H., Yang D. Z., Zhang L., Lv Y. (2022). Application of thermal analysis techniques in drug cocrystals. Chin. J. Pharm. 53 (3), 290–298. 10.16522/j.cnki.cjph.2022.03.002 [DOI] [Google Scholar]
- Wu C., You J., Wang X. (2018). Thermal decomposition mechanism and kinetics of gemcitabine. J. Anal. Appl. Pyrolysis 130, 118–126. 10.1016/j.jaap.2018.01.019 [DOI] [Google Scholar]
- Xiao Z. B., Guo M. M., Guo R. K., Tian C. L. (2013). Purity,Thermal decomposition kinetics and shelflife of artemisinin by thermal analysis. Chem. Ind. For. Prod. 33 (1), 13–20. 10.3969/j.issn.0253-2417.2013.01.003 [DOI] [Google Scholar]
- Zhang C. W., Wang C. Z., Tao R. (2016). Thermal decomposition kinetics of ginkgo biloba leaves polyprenol in nitrogen atmosphere. Int. J. Chem. Kinet. 48 (11), 671–678. 10.1002/kin.21023 [DOI] [Google Scholar]
- Zhang L., Zou Z. R. (2020). Research progress on alkaloid acetylcholinesterase inhibitors from natural products. Chin. Tradit. Herb. Drugs. 51 (2), 522–530. 10.7501/j.issn.0253-2670.2020.02.032 [DOI] [Google Scholar]
- Zhang P., Ji H., Hu Q. H. (2022). Research progress in clinical treatment of Alzheimer's disease and potential drugs from natural products. Acta Pharm. Sin. 57 (7), 1954–1961. 10.16438/j.0513-4870.2022-0226 [DOI] [Google Scholar]
- Zhang Q., Zhang F. M., Zhang C. S., Liu S. Z., Tian J. M., Wang S. H., et al. (2019). Catalytic asymmetric total syntheses of (‒)-Galanthamine and (‒)-Lycoramine. J. Org. Chem. 84, 12664–12671. 10.1021/acs.joc.9b01971 [DOI] [PubMed] [Google Scholar]
- Zhou M. H., Su L. (2008). RP-HPLC determination of related substances in galanthamine hydrobromide. Chin. J. Pharm. Anal. 28 (3), 466–469. 10.16155/j.0254-1793.2008.03.038 [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.

